Work

RTOG 0525: Exploratory Subset Analysis from a Randomized Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)

Year: 2011

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2011.06.265

Authors: M.P. Mehta, M. Wang, K. Aldape, R. Stupp, K.A. Jaeckle, D. Blumenthal, P. Brown, S. Erridge, W. Curran, M. Gilbert

Institutions: Northwestern University, RTOG Foundation, The University of Texas MD Anderson Cancer Center, University of Lausanne, Mayo Clinic in Florida, Tel Aviv Sourasky Medical Center, Medical College of Wisconsin, University of Edinburgh, Emory University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2091950894

FWCI: 0.153

Cites:

Cited by: 3

Related to: 10